![Eligibility for Disease Modifying Therapies (DMTs) in Dementia [A.I.] Artwork](https://www.buzzsprout.com/rails/active_storage/representations/redirect/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBCQ25CN3djPSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5e8ff14bbf0b5114c8e53e7b26466e82bd89b5f2/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdDVG9MWm05eWJXRjBPZ2hxY0djNkUzSmxjMmw2WlY5MGIxOW1hV3hzV3docEFsZ0NhUUpZQW5zR09nbGpjbTl3T2d0alpXNTBjbVU2Q25OaGRtVnlld1k2REhGMVlXeHBkSGxwUVRvUVkyOXNiM1Z5YzNCaFkyVkpJZ2x6Y21kaUJqb0dSVlE9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--1924d851274c06c8fa0acdfeffb43489fc4a7fcc/Podcast%20Logo.png)
Geriatric Neuroscience Research
>5 Episodes Every Single Week. Bringing you the latest research in geriatric neuroscience.
Geriatric Neuroscience Research
Eligibility for Disease Modifying Therapies (DMTs) in Dementia [A.I.]
•
Gavin
STUDIES:
Dobson R, Patterson K, Malik R, Mandal U, Asif H, Humphreys R, Payne M, Eng O, Huzzey L, Clare A, Green K. Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer’s disease. Journal of Neurology, Neurosurgery & Psychiatry. 2024 May 15.
Laurell AA, Venkataraman AV, Schmidt T, Montagnese M, Mueller C, Stewart R, Lewis J, Mundell C, Isaacs JD, Krishnan MS, Barber R. Estimating demand for potential disease-modifying therapies for Alzheimer's disease in the UK. The British Journal of Psychiatry. 2024 Jun;224(6):198-204.